ArticleBMC geriatrics2025
Anticholinergic and sedative medications use among community dwelling older adults: risk for polypharmacy and poor physical function.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advanced Drug Delivery Strategies in Geriatric Patients with Polypharmacy: Integrating Pharmacokinetics, Personalized Medicine, and Emerging Technologies.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnticholinergic and/or sedative mediations are one of the most commonly prescribed medication groups in older adults. This study aimed to assess the prevalence of anticholinergic and/or sedative mediations use in community dwelling older adults as well as potentially associated factors with their use.
methodsA cross sectional study was conducted among community dwelling older adults who accepted invitation for geriatric screening in the Public Education Centres (PEC) in Türkiye. The subgroup study population was selected among those who used at least one medication. The prevalence of anticholinergic and/or sedative mediations use, comprehensive geriatric tests, drug-drug interactions and polypharmacy were assessed. Statistical analysis was performed to identify associated factors with anticholinergic and/or sedative mediations use.
resultsA total of 608 older adults voluntarily participated in the study from the 16 PEC. Among these 372 were eligible (61%). The prevalence of anticholinergic and/or sedative medications use was 36% among the community dwelling older adults. Polypharmacy was present in 32% of the them. Drug-drug interactions involved anticholinergic and/or sedative medications was common (42%). Polypharmacy (p < 0.001) and poor physical function (frailty, p = 0.026; sarcopenia, p = 0.003; instrumental activities of daily living, p = 0.001; and activities of daily living, p = 0.045) were found to be associated with the use of anticholinergic and/or sedative medications in this study.
conclusionsWith common anticholinergic and/or sedative mediations use and its associated risk for polypharmacy, poor physical function and drug-drug interactions, their use must be balanced with their potential risks and benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.